[Federal Register Volume 71, Number 189 (Friday, September 29, 2006)]
[Notices]
[Pages 57570-57571]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-16021]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated June 1, 2006, and published in the Federal Register 
on June 8, 2006, (71 FR 33315), Mallinckrodt Inc., 3600 North Second 
Street, St. Louis, Missouri 63147, made application by renewal to the 
Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the basic classes of controlled substances listed in 
Schedules I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Codeine-N-oxide (9053).....................  I
Difenoxin (9168)...........................  I
Dihydromorphine (9145).....................  I
Morphine-N-oxide (9307)....................  I
Norlevorphanol (9634)......................  I
Normorphine (9313).........................  I
Tetrahydrocannabinols (7370)...............  I
Alfentanil (9737)..........................  II
Amphetamine (1100).........................  II
Ecgonine (9180)............................  II
Codeine (9050).............................  II
Dextropropoxyphene, bulk (9273)............  II
Dihydrocodeine (9120)......................  II
Diphenoxylate (9170).......................  II
Diprenorphine (9058).......................  II
Etorphine HCL (9059).......................  II
Fentanyl (9801)............................  II
Hydrocodone (9193).........................  II
Hydromorphone (9150).......................  II
Levo-alphacetylmethadol (9648).............  II
Levorphanol (9220).........................  II
Meperidine (9230)..........................  II
Methadone (9250)...........................  II
Methadone intermediate (9254)..............  II
Methamphetamine (1105).....................  II
Methylphenidate (1724).....................  II
Metopon (9260).............................  II
Morphine (9300)............................  II
Nabilone (7379)............................  II
Noroxymorphone (9668)......................  II
Opium extracts (9610)......................  II
Opium fluid extract (9620).................  II
Opium tincture (9630)......................  II
Opium, granulated (9640)...................  II
Opium, powdered (9639).....................  II
Oxycodone (9143)...........................  II
Oxymorphone (9652).........................  II
Phenazocine (9715).........................  II
Remifentanil (9739)........................  II
Sufentanil (9740)..........................  II
Thebaine (9333)............................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances for 
internal use and for sale to other companies.
    Since the publication of the Notice of Application, it has been 
determined that drug code 7360 (Marihuana) is not needed as a bulk 
manufacturing drug code for the company. The company has subsequently 
withdrawn their request to add this code to their current application 
for registration.

[[Page 57571]]

    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Mallinckrodt Inc. to manufacture the listed basic classes of controlled 
substances is consistent with the public interest at this time. DEA has 
investigated Mallinckrodt Inc. to ensure that the company's 
registration is consistent with the public interest. The investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with State and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the 
above named company is granted registration as a bulk manufacturer of 
the basic classes of controlled substances listed.

    Dated: September 20, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E6-16021 Filed 9-28-06; 8:45 am]
BILLING CODE 4410-09-P